Phase 1 study of ST101, a first-in-class peptide antagonist of CCAAT/enhancer-binding protein b (C/EBPb), in patients with advanced solid tumors, with a phase 2 expansion in patients with hormone receptor positive breast cancer (HR+ BC)
ST-101
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase 1 study of ST101, a first-in-class peptide antagonist of CCAAT/enhancer-binding protein b (C/EBPb), in patients with advanced solid tumors, with a phase 2 expansion in patients with hormone receptor positive breast cancer (HR+ BC) ### Output: ST-101